Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care

References

• National Institute for Health and Care Excellence (NICE)NG28: Type 2 diabetes in adults: management2015
   Google Scholar
• International Diabetes Federation (IDF)IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care2017
   Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes - 2017Diabetes Care201740Suppl 1S1S13527979885
   PubMedGoogle Scholar
• Healthcare Improvement ScotlandGuideline 154 Pharmacological management of glycaemic control in people with type 2 diabetes, in A national clinical guideline2017 Available from: http://sign.ac.uk/assets/sign154.pdfAccessed April 12, 2018
   Google Scholar
• WilkinsonSDouglasIStirnadel-FarrantHChanging use of antidiabetic drugs in the UK: trends in prescribing 2000–2017BMJ Open201887e022768
   Web of Science ®Google Scholar
• GourgariEWilhelmEEHassanzadehHArodaVRShoulsonIA comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety dataJ Diabetes Complications201731121719172728939018
   PubMed Web of Science ®Google Scholar
• FleischmanWAssociation between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological studyBMJ2016354i418927540015
   PubMed Web of Science ®Google Scholar
• HerrettEGallagherAMBhaskaranKData Resource Profile: Clinical Practice Research Datalink (CPRD)Int J Epidemiol201544382783626050254
   PubMed Web of Science ®Google Scholar
• ZoungasSWoodwardMLiQImpact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesDiabetologia201457122465247425226881
   PubMed Web of Science ®Google Scholar
• KoopmanRJMainousAGDiazVAGeeseyMEChanges in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000Ann Fam Med200531606315671192
   PubMed Web of Science ®Google Scholar
• Electronic Medicines Compendium (eMC)Summary of Product Characteristics: Metformin 500mg tablets 2017 Jan 2016. Available from: http://www.medicines.org.uk/emc/history/23244Accessed April 12, 2018
   Google Scholar
• ChamberlainJJHermanWHLealSPharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in DiabetesAnn Intern Med2017166857257828288484
   PubMed Web of Science ®Google Scholar
• MathurRBhaskaranKChaturvediNCompleteness and usability of ethnicity data in UK-based primary care and hospital databasesJ Public Health2014364684692
   Web of Science ®Google Scholar
• LeveyASStevensLASchmidCHA new equation to estimate glomerular filtration rateAnn Intern Med2009150960461219414839
   PubMed Web of Science ®Google Scholar
• MathurRBhaskaranKEdwardsEPopulation trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004-2014BMJ Open201772e014444
   Web of Science ®Google Scholar
• Hippisley-CoxJCouplandCDiabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary careBMJ2016352i145027029547
   PubMed Web of Science ®Google Scholar
• TebbothALeeSScowcroftADemographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General PracticeClin Ther20163881825183227491279
   PubMed Web of Science ®Google Scholar
• ReedCHongJNovickDLenox-SmithAHappichMIncidence of diabetic peripheral neuropathic pain in primary care - a retrospective cohort study using the United Kingdom General Practice Research DatabasePragmat Obs Res20134273727774022
   PubMedGoogle Scholar
• HollingworthWBiswasMMaishmanRLThe healthcare costs of heart failure during the last five years of life: A retrospective cohort studyInt J Cardiol201622413213827648982
   PubMed Web of Science ®Google Scholar
• DenaxasSCGeorgeJHerrettEData resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)Int J Epidemiol20124161625163823220717
   PubMed Web of Science ®Google Scholar
• Ministry of Housing, C.L.GEnglish indices of deprivation 2015 2015 December 2017. Available from: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015Accessed April 12, 2018
   Google Scholar
• LiangHKennedyCManneSLinJHDolinPMonitoring for proteinuria in patients with type 2 diabetes mellitusBMJ Open Diabetes Res Care201531e000071
   Google Scholar
• HosmerDWJrLemeshowSApplied Logistic Regression2nd edHoboken, New JerseyJohn Wiley & Sons2000398
   Google Scholar
• GreenlandSModeling and variable selection in epidemiologic analysisAm J Public Health19897933403492916724
   PubMed Web of Science ®Google Scholar
• HerrettEShahADBoggonRCompleteness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort studyBMJ2013346f235023692896
   PubMed Web of Science ®Google Scholar
• RubinDBMultiple Imputation for Nonresponse in SurveysNew YorkWiley1987
   Google Scholar
• MorrisTPWhiteIRRoystonPTuning multiple imputation by predictive mean matching and local residual drawsBMC Med Res Methodol20141417524903709
   PubMed Web of Science ®Google Scholar
• MehtaSWellsSJacksonRHarrisonJKerrAThe effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage studyN Z Med J201612914431829
   Google Scholar
• Medicines and Healthcare products Regulatory AgencyPioglitazone: risk of bladder cancer. Drug Safety. Update. 2011 Available from: https://www.gov.uk/drug-safety-update/pioglitazone-risk-of-bladder-cancerAccessed April 12, 2018
   Google Scholar
• NissenSEWolskiKEffect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesN Engl J Med2007356242457247117517853
   PubMed Web of Science ®Google Scholar
• Electronic Medicines Compendium (eMC)Summary Product Characteristics: Invokana 100 mg and 300 mg film-coated tabletsDapagliflozin Available from: http://www.medicines.org.uk/emc/medicine/28400Accessed April 12, 2018
   Google Scholar
• InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care201538114014925538310
   PubMed Web of Science ®Google Scholar
• LublóyÁFactors affecting the uptake of new medicines: a systematic literature reviewBMC Health Serv Res201414146925331607
   PubMed Web of Science ®Google Scholar
• KirkmanMSBriscoeVJClarkNDiabetes in older adultsDiabetes Care201235122650266423100048
   PubMed Web of Science ®Google Scholar
• NgJMMellorDDMassonEAAllanBJSulphonyurea as a cause of severe hypoglycaemia in the communityPrim Care Diabetes201041616320064751
   PubMed Web of Science ®Google Scholar
• WinocourPManaging hyperglycaemia in patients with diabetes and diabetic nephropathy-chronic kidney diseaseAssoc Br Clin Diabetol2018
   Google Scholar
• MillettCGrayJSaxenaSNetuveliGKhuntiKMajeedAEthnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes StudyPLoS Med200746e19117564486
   PubMed Web of Science ®Google Scholar
• NealBPerkovicVMahaffeyKWCanagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesN Engl J Med2017377764465728605608
   PubMed Web of Science ®Google Scholar
• ZinmanBWannerCLachinJMEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesN Engl J Med2015373222117212826378978
   PubMed Web of Science ®Google Scholar